Cargando…

A role for interleukin-1 receptor antagonism in severe COVID-19?

Detalles Bibliográficos
Autores principales:	Tattersall, Rachel S, McGonagle, Dennis, Manson, Jessica J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352494/ https://www.ncbi.nlm.nih.gov/pubmed/34396155 http://dx.doi.org/10.1016/S2665-9913(21)00249-6

Ejemplares similares

Increased cardiovascular mortality in African Americans with COVID-19
por: McGonagle, Dennis, et al.
Publicado: (2020)

Stimulating severe COVID-19: the potential role of GM-CSF antagonism
por: Leavis, Helen L, et al.
Publicado: (2022)

Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case series
por: Flower, Luke, et al.
Publicado: (2021)

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
por: McGonagle, Dennis, et al.
Publicado: (2020)

Defining the scourge of COVID-19 hyperinflammatory syndrome
por: Cron, Randy Q, et al.
Publicado: (2020)

Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2022)

A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19
por: McGonagle, Dennis, et al.
Publicado: (2021)

Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection
por: McGonagle, Dennis, et al.
Publicado: (2020)

When Wnts antagonize Wnts
por: Weidinger, Gilbert, et al.
Publicado: (2003)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Immune cartography of macrophage activation syndrome in the COVID-19 era
por: McGonagle, Dennis, et al.
Publicado: (2021)

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
por: Gandini, Lucia, et al.
Publicado: (2023)

The Role of Biological and Small Molecule Therapy in the Management of Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2013)

The role of interleukin (IL)-23 in regulating pain in arthritis
por: Lee, Kevin M.-C., et al.
Publicado: (2022)

Azithromycin for severe COVID-19
por: Oldenburg, Catherine E, et al.
Publicado: (2020)

Health-care workers recovered from natural SARS-CoV-2 infection should be exempt from mandatory vaccination edicts
por: McGonagle, Dennis G
Publicado: (2022)

COVID-19 severity and obesity: are MAIT cells a factor?
por: McCarthy, Cormac, et al.
Publicado: (2021)

Pulmonary intravascular coagulopathy in COVID-19 pneumonia – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2020)

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
por: McGonagle, Dennis, et al.
Publicado: (2020)

Observational research on severe COVID-19 in diabetes
por: Stehouwer, Coen D A
Publicado: (2021)

COVID-19 vasculitis and novel vasculitis mimics
por: McGonagle, Dennis, et al.
Publicado: (2021)

Clinical course and mortality risk of severe COVID-19
por: Weiss, Paul, et al.
Publicado: (2020)

Epidemiology of severe COVID-19 from South Africa
por: Madhi, Shabir A, et al.
Publicado: (2021)

Are women with asthma at increased risk for severe COVID-19?
por: Fernando, Mario, et al.
Publicado: (2021)

Sulfasalazine: a risk factor for severe COVID-19?
por: Konig, Maximilian F, et al.
Publicado: (2022)

The effects of antihypertensive medications on severity and outcomes of COVID19
por: Agirbasli, Mehmet
Publicado: (2022)

Severe COVID-19 pneumonitis and timing of birth in women
por: Calvert, Clara, et al.
Publicado: (2023)

Radiation Recall Phenomenon Following COVID-19 Vaccination
por: Stewart, Rachel, et al.
Publicado: (2021)

What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis – the first 50 years
por: McGonagle, Dennis, et al.
Publicado: (2008)

Correction: What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis – the first 50 years
por: McGonagle, Dennis, et al.
Publicado: (2009)

Severe mental illness and European COVID-19 vaccination strategies
por: De Picker, Livia J, et al.
Publicado: (2021)

Mounting evidence of impaired viral control in severe COVID-19
por: Bermejo-Martin, Jesus F, et al.
Publicado: (2021)

Who, what, and when—effective therapy for severe COVID-19
por: Kelmenson, Daniel A, et al.
Publicado: (2022)

Severe COVID-19 and preexisting hypertension: a matter of age?
por: Yamazaki, Osamu, et al.
Publicado: (2022)

A Proposed Classification of the Immunological Diseases
por: McGonagle, Dennis, et al.
Publicado: (2006)

Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?
por: Zhang, Shen-Ying, et al.
Publicado: (2020)

Treatment for severe acute respiratory distress syndrome from COVID-19
por: Matthay, Michael A, et al.
Publicado: (2020)

Will helminth co-infection modulate COVID-19 severity in endemic regions?
por: Bradbury, Richard S., et al.
Publicado: (2020)

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
por: Leshem, Eyal, et al.
Publicado: (2021)

Baricitinib for patients with severe COVID-19—time to change the standard of care?
por: Supady, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_59gc2mgmtgjbcu4dhiprpo07k9